Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO responses to European Union and Global Public Consultations

ESMO-Responses-to-European-Union-and-Global-Public-Consultations-1000x250px

The European Commission and the World Health Organization, among others, often seek the views and opinions of citizens and stakeholders through so-called public consultations when they develop policy and legislation.

The objective of public consultations is to provide external stakeholders and citizens an opportunity to provide input early in the decision-making process to express views on the scope, priorities and added value of new initiatives, or evaluations of existing policies and laws. The input of oncology experts in this process is crucial in order to represent the field of cancer, and help influence and shape legislation at EU and global levels. The results of public consultations guide the EU and WHO’s work throughout the policy cycle.

ESMO has submitted several responses to various consultations in order to express the needs and views of the oncology community on the areas European and global health authorities need to work on, which you can find below.

ESMO Responses

Pharmaceutical Strategy for Europe: 
Europe’s Beating Cancer Plan:

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings